GANGLIONEUROBLASTOMA
Clinical trials for GANGLIONEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new GANGLIONEUROBLASTOMA trials appear
Sign up with your email to follow new studies for GANGLIONEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New proton beam therapy aims to cut radiation harm in kids with neuroblastoma
Disease control Recruiting nowThis study is testing a precise type of radiation called proton beam therapy for children with neuroblastoma, a nerve cell cancer. The goal is to see if this treatment can control the disease while causing fewer long-term side effects than standard radiation. About 30 participant…
Matched conditions: GANGLIONEUROBLASTOMA
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 04:55 UTC
-
Engineered immune cells take aim at childhood cancer
Disease control Recruiting nowThis study tests a new treatment using specially designed immune cells (CAR-NK cells) that target two proteins on neuroblastoma cells. It is for children and young adults aged 1 to 21 whose cancer has returned or not responded to standard treatments. The goal is to find a safe do…
Matched conditions: GANGLIONEUROBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated May 26, 2026 04:53 UTC
-
Immune booster trial offers new hope for kids with stubborn nerve cancer
Disease control Recruiting nowThis Phase 3 trial tests a powerful mix of chemotherapy, immunotherapy, and the child's own immune cells (natural killer cells) for children aged 1.5 to 18 with high-risk neuroblastoma that did not respond to initial treatment or has returned. The goal is to shrink tumors and imp…
Matched conditions: GANGLIONEUROBLASTOMA
Phase: PHASE3 • Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New hope for kids with tough cancer: targeted radiation or pill added to standard care
Disease control Recruiting nowThis study tests whether adding a radioactive drug (131I-MIBG) or a targeted pill (lorlatinib) to standard therapy helps children with high-risk neuroblastoma live longer without the cancer coming back. About 750 children and young adults (ages 1 to 30) with newly diagnosed high-…
Matched conditions: GANGLIONEUROBLASTOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 22, 2026 13:53 UTC